Anthony Adame
About
Anthony Adame is a scholar working on Physiology, Neurology and Cellular and Molecular Neuroscience.
According to data from OpenAlex, Anthony Adame has authored 110 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Physiology, 40 papers in Neurology and 35 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anthony Adame's work include Parkinson's Disease Mechanisms and Treatments (40 papers), Alzheimer's disease research and treatments (34 papers) and Cholinesterase and Neurodegenerative Diseases (17 papers). Anthony Adame is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (40 papers), Alzheimer's disease research and treatments (34 papers) and Cholinesterase and Neurodegenerative Diseases (17 papers). Anthony Adame collaborates with scholars based in United States, Austria and South Korea. Anthony Adame's co-authors include Eliezer Masliah, Edward Rockenstein, Leslie Crews, Michael Mante, Brian Spencer, Christina Patrick, Kiren Ubhi, Margarita Trejo, Makoto Hashimoto and Rewati Potkar and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
In The Last Decade
Anthony Adame
109 papers receiving 9.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anthony Adame United States | 59 | 3.6k | 3.2k | 3.1k | 2.8k | 2.4k | 110 | 9.4k | ||
| Leslie Crews United States | 49 | 3.2k 0.9× | 2.4k 0.7× | 3.1k 1.0× | 2.1k 0.8× | 1.7k 0.7× | 90 | 8.8k | ||
| Jonathan D. Glass United States | 48 | 1.7k 0.5× | 2.9k 0.9× | 2.7k 0.9× | 1.7k 0.6× | 2.1k 0.9× | 131 | 8.6k | ||
| Margaret Mallory United States | 58 | 8.0k 2.2× | 4.2k 1.3× | 4.3k 1.4× | 5.7k 2.1× | 3.2k 1.3× | 91 | 14.5k | ||
| Brian Spencer United States | 43 | 2.5k 0.7× | 2.8k 0.9× | 3.0k 1.0× | 1.7k 0.6× | 1.4k 0.6× | 77 | 7.8k | ||
| Jonathan D. Geiger United States | 46 | 2.2k 0.6× | 522 0.2× | 3.1k 1.0× | 2.1k 0.8× | 1.2k 0.5× | 163 | 8.2k | ||
| David H. Cribbs United States | 53 | 5.8k 1.6× | 873 0.3× | 3.9k 1.3× | 2.3k 0.8× | 3.1k 1.3× | 164 | 11.1k | ||
| Wolfgang J. Streit United States | 62 | 4.0k 1.1× | 1.5k 0.5× | 3.4k 1.1× | 4.3k 1.6× | 10.2k 4.2× | 144 | 16.3k | ||
| Carmela R. Abraham United States | 48 | 4.1k 1.1× | 587 0.2× | 3.7k 1.2× | 1.4k 0.5× | 1.7k 0.7× | 126 | 9.1k | ||
| Tsuneya Ikezu United States | 51 | 3.1k 0.9× | 662 0.2× | 4.8k 1.6× | 1.0k 0.4× | 3.1k 1.3× | 132 | 9.2k | ||
| Li Gan United States | 59 | 3.9k 1.1× | 1.2k 0.4× | 4.5k 1.5× | 2.2k 0.8× | 2.5k 1.0× | 165 | 10.9k |
Countries citing papers authored by Anthony Adame
Since
Specialization
Citations
This map shows the geographic impact of Anthony Adame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Adame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Adame more than expected).
Fields of papers citing papers by Anthony Adame
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anthony Adame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Adame. The network helps show where Anthony Adame may publish in the future.
Co-authorship network of co-authors of Anthony Adame
This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Adame. A scholar is included among the top collaborators of Anthony Adame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Adame. Anthony Adame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Spencer, Brian, Sven Brüschweiler, Marco Sealey‐Cardona, et al.. (2018). Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders. Acta Neuropathologica. 136(1). 69–87.
2.
Kim, Changyoun, Brian Spencer, Edward Rockenstein, et al.. (2018). Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Molecular Neurodegeneration. 13(1). 43–43.
3.
Rockenstein, Edward, Gary R. Ostroff, Florentina Rus, et al.. (2017). Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies. Journal of Neuroscience. 38(4). 1000–1014.
4.
Chen, Shu G., Vilius Stribinskis, Madhavi J. Rane, et al.. (2016). Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans. Scientific Reports. 6(1). 34477–34477.
5.
Price, D. L., Edward Rockenstein, Michael Mante, et al.. (2016). Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies. Scientific Reports. 6(1). 29523–29523.
6.
Kim, Changyoun, Edward Rockenstein, Brian Spencer, et al.. (2015). Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy. Cell Reports. 13(4). 771–782.
7.
Spencer, Brian, et al.. (2015). Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease. Journal of Biological Chemistry. 291(4). 1905–1920.
8.
Kim, Changyoun, Emmanuel A. Ojo-Amaize, Brian Spencer, et al.. (2015). Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease. Journal of Neuroinflammation. 12(1). 236–236.
9.
Desplats, Paula, Wilmar Dumaop, Davey M. Smith, et al.. (2013). Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 80(15). 1415–1423.
10.
Kwan, Wanda, Anna Magnusson, Austin Chou, et al.. (2012). Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease. Journal of Neuroscience. 32(1). 133–142.
11.
Spencer, Brian, Robert A. Marr, Rewati Potkar, et al.. (2011). Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Aβ Toxicity in a Mouse Model of Alzheimer's Disease. PLoS ONE. 6(1). e16575–e16575.
12.
Lessig, Stephanie, Kiren Ubhi, Douglas Galasko, et al.. (2010). Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 21(11). 756–760.
13.
Masliah, Eliezer, Fang Xie, Edward Rockenstein, et al.. (2010). Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice. Neuroscience. 169(1). 488–494.
14.
Rose, J. Bart, Leslie Crews, Edward Rockenstein, et al.. (2009). Neuropeptide Y Fragments Derived from Neprilysin Processing Are Neuroprotective in a Transgenic Model of Alzheimer's Disease. Journal of Neuroscience. 29(4). 1115–1125.
15.
Shankar, Ganesh M., Malcolm A. Leissring, Anthony Adame, et al.. (2009). Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life. Neurobiology of Disease. 36(2). 293–302.
16.
Ubhi, Kiren, Edward Rockenstein, Edith Doppler, et al.. (2009). Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin. Acta Neuropathologica. 117(6). 699–712.
17.
Spencer, Brian, Robert A. Marr, Edward Rockenstein, et al.. (2008). Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neuroscience. 9(1). 109–109.
18.
Rockenstein, Edward, Michael Mante, Michael Alford, et al.. (2005). High β-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-β Levels. Journal of Biological Chemistry. 280(38). 32957–32967.
19.
Rockenstein, Edward, Anthony Adame, Michael Mante, et al.. (2004). Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer?s disease with the neurotrophic compound Cerebrolysin?. Journal of Neural Transmission. 112(2). 269–282.
20.
Langford, Dianne, Anthony Adame, Igor Grant, et al.. (2003). Patterns of Selective Neuronal Damage in Methamphetamine-User AIDS Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(5). 467–474.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leslie Crews Breakdown of academic impact, for papers by Jonathan D. Glass Breakdown of academic impact, for papers by Margaret Mallory Breakdown of academic impact, for papers by Brian Spencer Breakdown of academic impact, for papers by Jonathan D. Geiger Breakdown of academic impact, for papers by David H. Cribbs Breakdown of academic impact, for papers by Wolfgang J. Streit Breakdown of academic impact, for papers by Carmela R. Abraham Breakdown of academic impact, for papers by Tsuneya Ikezu Breakdown of academic impact, for papers by Li Gan